HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

SB 2134 prohibits health insurance plans, Medicaid, and pharmacy benefit managers from denying coverage or imposing extra approval steps (like prior authorization) for FDA-approved HIV/AIDS treatment drugs. It directly affects people living with HIV/AIDS who rely on these medications, ensuring they can access prescribed treatments without coverage barriers. The bill requires plans to cover at least one therapeutically equivalent version of each HIV treatment drug without prior authorization, while allowing limited restrictions for other equivalent options. If enacted, the law would take effect July 1, 2026, but it died in committee on February 3, 2026.